menu
    • menu
    [{"orgOrder":0,"company":"ALK-ABELLO INC","sponsor":"ARS Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Hormone","year":"2024","type":"Licensing Agreement","leadProduct":"Epinephrine","moa":"Adrenergic receptor","graph1":"Immunology","graph2":"Approved FDF","graph3":"ALK-ABELLO INC","amount2":0.46999999999999997,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Immunology","amount2New":0.46999999999999997,"dosageForm":"Spray","sponsorNew":"ALK-ABELLO INC \/ ALK-ABELLO INC","highestDevelopmentStatusID":"15","companyTruncated":"ALK-ABELLO INC \/ ALK-ABELLO INC"},{"orgOrder":0,"company":"ALK-ABELLO INC","sponsor":"ARS Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Hormone","year":"2025","type":"Agreement","leadProduct":"Epinephrine","moa":"Adrenergic receptor","graph1":"Immunology","graph2":"Approved FDF","graph3":"ALK-ABELLO INC","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Spray","sponsorNew":"ALK-ABELLO INC \/ ALK-ABELLO INC","highestDevelopmentStatusID":"15","companyTruncated":"ALK-ABELLO INC \/ ALK-ABELLO INC"},{"orgOrder":0,"company":"ALK-ABELLO INC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"12 SQ-Bet Betula Verrucosa","moa":"Undisclosed","graph1":"Immunology","graph2":"Approved FDF","graph3":"ALK-ABELLO INC","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"ALK-ABELLO INC \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"ALK-ABELLO INC \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by ALK-ABELLO INC

    Menu

    ALK-ABELLO INC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Epinephrine

                            Therapeutic Area : Immunology

                            Study Phase : Approved FDF

                            Recipient : ARS Pharmaceuticals

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            ARS Inks Co-Promotion Deal with ALK-Abelló to Expand Reach of Neffy Nasal Spray

                            Details : Under the agreement, ARS will expand the approved product Neffy (epinephrine) by parterning with ALK-Abelló. It is being indicated for the treatment of Type I allergic reactions including anaphylaxis.

                            Product Name : Neffy

                            Product Type : Hormone

                            Upfront Cash : Undisclosed

                            May 02, 2025

                            Lead Product(s) : Epinephrine

                            Therapeutic Area : Immunology

                            Highest Development Status : Approved FDF

                            Recipient : ARS Pharmaceuticals

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Birch Pollen Extract,12 SQ-Bet Betula Verrucosa

                            Therapeutic Area : Immunology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            ITULAZAX® Tree Pollen Tablet Approved for Treatment of Children in Europe

                            Details : Itulazax (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged five to 17 has been approved by the health authorities in 17 EU countries.

                            Product Name : Itulazax

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            April 23, 2025

                            Lead Product(s) : Birch Pollen Extract,12 SQ-Bet Betula Verrucosa

                            Therapeutic Area : Immunology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            ALK-ABELLO INC

                            U.S.A arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Epinephrine

                            Therapeutic Area : Immunology

                            Study Phase : Approved FDF

                            Recipient : ARS Pharmaceuticals

                            Deal Size : $465.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            ARS & ALK Partner to Commercialize neffy® in Europe, Canada, & More

                            Details : ALK exclusive rights to commercialize EURneffy (epinephrine nasal spray), the first and only needle-free emergency treatment for Type I allergic reactions including anaphylaxis.

                            Product Name : EURneffy

                            Product Type : Hormone

                            Upfront Cash : $145.0 million

                            November 11, 2024

                            Lead Product(s) : Epinephrine

                            Therapeutic Area : Immunology

                            Highest Development Status : Approved FDF

                            Recipient : ARS Pharmaceuticals

                            Deal Size : $465.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth